Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Gain Therapeutics Inc (GANX)

Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Gain Therapeutics, Inc. to Present at Biotech Showcase 2025 on GT-02287 for Parkinson's Disease Quiver Quantitative, Inc. - Wed Dec 11, 5:54PM CST

Gain Therapeutics will present on GT-02287, a Parkinson's disease treatment, at Biotech Showcase 2025.Quiver AI SummaryGain Therapeutics, Inc. has announced that Gene Mack, its Chief Financial Officer...

GANX : 1.5600 (-0.64%)
Gain Therapeutics To Present At Biotech Showcase 2025 GlobeNewswire - Wed Dec 11, 7:30AM CST

GANX : 1.5600 (-0.64%)
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update GlobeNewswire - Thu Nov 14, 3:05PM CST

GANX : 1.5600 (-0.64%)
Gain Therapeutics Presents Data at 36ᵗʰ EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2 GlobeNewswire - Wed Oct 23, 7:00AM CDT

GANX : 1.5600 (-0.64%)
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics GlobeNewswire - Tue Oct 15, 6:00AM CDT

GANX : 1.5600 (-0.64%)
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference GlobeNewswire - Wed Oct 9, 7:30AM CDT

GANX : 1.5600 (-0.64%)
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024 GlobeNewswire - Mon Oct 7, 6:00AM CDT

GANX : 1.5600 (-0.64%)
Gain Therapeutics to Participate at Upcoming Investor Conferences GlobeNewswire - Thu Oct 3, 6:00AM CDT

GANX : 1.5600 (-0.64%)
Gain Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Business Update Globe Newswire - Mon Aug 8, 2022

Presented Additional Supportive Preclinical Data for Lead Candidate GT-02287 at Recent Medical Meetings Further Validating Therapeutic Potential and...

GANX : 1.5600 (-0.64%)
Gain Therapeutics to Participate at the Jefferies Healthcare Conference Globe Newswire - Thu Jun 2, 2022

BETHESDA, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming...

GANX : 1.5600 (-0.64%)

Barchart Exclusives

3 Highly-Rated Dividend Stocks To Buy on the Dip Barchart - Fri Dec 20, 6:00PM CST
Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot